News
12-15-2008, 02:07 AM
An interim analysis of a breast cancer prevention study using exemestane (Aromasin) finds an "acceptable" level of bone loss.
More... (http://www.news-medical.net/?id=44186)
More... (http://www.news-medical.net/?id=44186)
View Full Version : Planned safety analysis of a breast cancer prevention study reveals encouraging news